Position in GH
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,648,229
+$376,110 QoQ
Shares Held
10,986
-20.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#274
of 594 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Tema ETFs LLC holds $20,010,707 across 13 Diagnostics & Research names. GH ranks #4 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
13,946 | $6,991,966 | |
| 2 | DHR |
Danaher Corp /De/
|
19,114 | $3,640,834 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
3,934 | $2,071,014 | |
| 4 | GH |
Guardant Health, Inc.
This page
|
10,986 | $1,648,229 | |
| 5 | WAT |
Waters Corp /De/
|
4,030 | $1,511,411 | |
| 6 | NTRA |
Natera, Inc.
|
4,238 | $1,150,405 | |
| 7 | A |
Agilent Technologies, Inc.
|
5,060 | $672,119 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
3,370 | $651,151 |
All Filings in GH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,648,229 | 10,986 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $1,272,119 | 13,772 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $808,438 | 7,915 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $642,606 | 10,285 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $590,654 | 11,350 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $432,816 | 10,160 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,103,466 | 36,120 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||